Xenetic Biosciences, Inc.
For the period ended Sep 14, 2026. Filed Sep 16, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Sep 14, 2026 · Filed Sep 16, 2026
Use the contents to explore the available documents and sections.
XBIO$1.87+0.3%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.